Increasing diagnostic accuracy with next-gen AI
Siemens Healthineers is committed to fight breast cancer and, moreover, is committed to be your partner along the entire Breast Health Journey. Join our innovation talk, to get the 360° perspective in breast health and to learn more about our digital solutions in breast health, to empower your decisions in every step of the Breast Health Journey.
Tomorrow’s Technology Today: The Migration to Wide-Angle Breast Tomosynthesis
Interviews with the lead breast radiologist Dr. Anthony Antonoplos and the manager Jacqui Appel of Mary Jo Cropper Center for Breast Imaging: A case study of a breast imaging center in Cincinnati, OH who made the transition easy when it adopted Wide-Angle Breast Tomosynthesis technology. (Clinical Focus Talks, Nov. 2021)
Artificial Intelligence in Mammography: Leveling the Playing Field for Global Disparities
In her keynote talk Prof. Dr. Rachel Brem (George Washington University, Washington, USA) reviews the impact of Artificial intelligence (AI) in cancer detection as well as compares AI to radiologist interpretation with 2D and 3D mammograms. (Clinical Focus Talks, Nov. 2021)
Adventures with Contrast Enhanced Mammography
Dr. Noel Bergquist, an assistant professor at the University of Tennessee at Knoxville's Breast Center, presents a diverse series of cases, after a brief review of Siemens' Titanium Contrast Enhanced Mammography (TICEM). (Clinical Focus Talks, Nov. 2021)
Differential breast diagnostics: Case discussions based on state-of-the-art imaging
In this online seminar, Dr. Clara Park (Wiesbaden, Germany) discusses screening and diagnostic cases from her clinical routine. She explains the strengths, advantages and limitations of each breast imaging technique in the detection and characterization of lesions. (EUSOBI ASM, Oct. 2021)
Interval cancers in screening with breast tomosynthesis: Results and cases from the Malmö trial
In this online seminar, Dr. Kristin Johnson and Prof. Dr. Sophia Zackrisson (Malmö, Sweden) discuss results and exemplary cases from the Malmö trial with the audience. (EUSOBI ASM, Oct. 2021)
What do lesions look like on different breast imaging modalities?
Dr. Paola Clauser (University of Vienna, Austria) discusses clinical cases from her daily routine and explains the appearance of lesions in morphological imaging like in digital mammography and tomosynthesis compared to functional imaging like breast MRI and contrast enhanced mammography (EUSOBI, Oct.2020).
Risk-adjusted Breast Cancer Screening Strategies (ECR Symposium)
After an introduction by Associate Prof. Dr. Luis Pina (Pamplona/Spain), Dr. Ritse Mann (Nijmegen/Netherlands) and Prof. Dr. Francesco Sardanelli (Milan/Italy) give an overview about risk-adjusted breast cancer screening strategies (ECR Symposium, July 2020).
AI in Breast Screening and Diagnostics – the Evidence and Clinical Implementation
Prof. Dr. Nico Karssemeijer (ScreenPoint Medical, Nijmegen/The Netherlands) and Henny Rijken (ScreenPoint Medical, Nijmegen/The Netherlands) talk about Artificial Intelligence (AI) in breast screening and diagnostics and give an overview about evidence and clinical implementation (July 2020).